EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+3.61%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$444M
AUM Growth
+$444M
(-27%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-39.3%
Top 10 Holdings %
Top 10 Hldgs %
61.1%
Holding
76
New
8
Increased
11
Reduced
27
Closed
24
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$24.7M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$21.6M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$12M |
| 4 |
OraSure Technologies
OSUR
|
$11.4M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
$6.87M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$39.5M |
| 2 |
AstraZeneca
AZN
|
$27.5M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$27M |
| 4 |
Danaher
DHR
|
$16.5M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$15.7M |
Sector Composition
| 1 | Healthcare | 98.23% |
| 2 | Communication Services | 1.5% |
| 3 | Financials | 0.04% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFMD
26
DELISTED
Affimed
AFMD
| $4.22M | 0.94% |
1,245,458
+302,469
| +32% | +$1.03M |
|
27
BioCryst Pharmaceuticals
BCRX
$1.7B
| $3.93M | 0.87% |
1,143,211
-3,704,581
| -76% | -$12.7M |
|
|
OXFD
28
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.43M | 0.76% |
293,277
-56,861
| -16% | -$665K |
|
|
29
AstraZeneca
AZN
$254B
| $3.34M | 0.74% |
60,936
-501,215
| -89% | -$27.5M |
|
30
Mersana Therapeutics
MRSN
$36M
| $2.61M | 0.58% |
+140,000
| New | +$2.61M |
|
31
Sanofi
SNY
$122B
| $2.5M | 0.55% |
49,778
| – | – |
|
32
GSK
GSK
$79.6B
| $2.45M | 0.55% |
64,372
-162,891
| -72% | -$6.21M |
|
33
Apellis Pharmaceuticals
APLS
$3.52B
| $2.45M | 0.54% |
81,267
-339,665
| -81% | -$10.2M |
|
34
Celldex Therapeutics
CLDX
$1.56B
| $2.23M | 0.5% |
150,494
-562,204
| -79% | -$8.34M |
|
35
Carisma Therapeutics
CARM
$16.8M
| $2.18M | 0.49% |
1,559,824
-440,176
| -22% | -$616K |
|
36
QuidelOrtho
QDEL
$1.9B
| $2.05M | 0.46% |
+9,343
| New | +$2.05M |
|
37
Prothena Corp
PRTA
$447M
| $1.97M | 0.44% |
197,028
+44,815
| +29% | +$448K |
|
|
OTIC
38
DELISTED
Otonomy, Inc.
OTIC
| $1.67M | 0.37% |
412,500
-188,663
| -31% | -$764K |
|
39
KalVista Pharmaceuticals
KALV
$731M
| $1.35M | 0.3% |
107,300
+17,494
| +19% | +$220K |
|
|
CNCE
40
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.02M | 0.23% |
103,829
-129,154
| -55% | -$1.27M |
|
41
Liquidia Corp
LQDA
$2.54B
| $899K | 0.2% |
182,751
-676,973
| -79% | -$3.33M |
|
42
Solid Biosciences
SLDB
$435M
| $623K | 0.14% |
307,024
-100,000
| -25% | -$203K |
|
43
Protara Therapeutics
TARA
$125M
| $611K | 0.14% |
36,310
-10,000
| -22% | -$168K |
|
44
scPharmaceuticals
SCPH
$297M
| $489K | 0.11% |
65,605
-181,814
| -73% | -$1.35M |
|
45
Sarepta Therapeutics
SRPT
$1.93B
| $266K | 0.06% |
1,897
-69,834
| -97% | -$9.81M |
|
|
TLGT
46
DELISTED
Teligent, Inc
TLGT
| $220K | 0.05% |
305,423
-49,575
| -14% | -$35.7K |
|
47
GoHealth
GOCO
$80.1M
| $171K | 0.04% |
+13,130
| New | +$171K |
|
48
Air Lease Corp
AL
$7.14B
| – | – |
0
| – | – |
|
49
Align Technology
ALGN
$9.79B
| – | – |
0
| – | – |
|
|
AUTL
50
Autolus Therapeutics
AUTL
$399M
| – | – |
-258,360
| Closed | -$4.14M |
|